ロード中...
Management of acute vertigo with betahistine
This open, prospective study was carried out in 29 outpatients of vertigo with Betahistine treatment at a dose of 16 mg three times daily far a maximum treatment period of 6 weeks or earlier until remission of vertigo attacks. The evaluations were carried out based on three parameters such as freque...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer India
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3451274/ https://ncbi.nlm.nih.gov/pubmed/23119656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/BF03000335 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|